|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
EBOOKCENTRAL_ocn747105427 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
110818s2010 nyua ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d OCLCF
|d NLGGC
|d OCLCO
|d YDXCP
|d EBLCP
|d OCLCQ
|d ZCU
|d MERUC
|d ICG
|d TOF
|d OCLCO
|d OCLCQ
|d REC
|d STF
|d M8D
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 904252166
|a 909457459
|a 923654862
|
| 020 |
|
|
|a 9781616686390
|q (electronic bk.)
|
| 020 |
|
|
|a 1616686391
|q (electronic bk.)
|
| 029 |
1 |
|
|a AU@
|b 000054183020
|
| 029 |
1 |
|
|a DEBBG
|b BV043148828
|
| 029 |
1 |
|
|a DEBBG
|b BV044087354
|
| 029 |
1 |
|
|a DEBSZ
|b 421559454
|
| 029 |
1 |
|
|a GBVCP
|b 803622899
|
| 035 |
|
|
|a (OCoLC)747105427
|z (OCoLC)904252166
|z (OCoLC)909457459
|z (OCoLC)923654862
|
| 050 |
|
4 |
|a RC667
|b .H67eb v. 2
|
| 060 |
|
4 |
|a 2010 K-357
|
| 060 |
|
4 |
|a WG 120
|b H8113 2010
|
| 072 |
|
7 |
|a MED
|x 010000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.1
|2 22
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Horizons in world cardiovascular research.
|n Volume 2 /
|c Eleanor H. Bennington, editor.
|
| 260 |
|
|
|a New York :
|b Nova Biomedical Books,
|c ©2010.
|
| 300 |
|
|
|a 1 online resource (xv, 303 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Horizons in world cardiovascular research series
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a HORIZONS IN WORLDCARDIOVASCULAR RESEARCH. VOLUME 2 -- HORIZONS IN CARDIOVASCULAR RESEARCH -- CONTENTS -- PREFACE -- BENEFICIAL CLINICAL EFFECTS OF PERHEXILINEIN CARDIAC PATIENTS: MULTIPLE BIOCHEMICALMECHANISMS -- ABSTRACT -- CLINICAL APPLICATIONS OF PERHEXILINE -- Stable and Unstable Angina Pectoris -- Aortic Stenosis -- Heart Failure -- PHARMACOKINETICS AND TOXICITY OF PERHEXILINE -- PHARMACOLOGY OF PERHEXILINE -- Hemodynamics -- Ion Channels -- Metabolic Shift -- Interactions with NO Signaling Pathway -- NO resistance in cardiovascular disease states
|
| 505 |
8 |
|
|a Mechanisms of NO resistanceAmelioration of platelet NO resistance by perhexiline -- Oxidative Stress and Inflammation -- CONCLUSION AND FUTURE PERSPECTIVES -- REFERENCES -- DRUG-INDUCED VALVULAR HEART DISEASE -- ABSTRACT -- 1. INTRODUCTION -- 2. PATHOPHYSIOLOGY OF DRUG-INDUCED VALVULAR HEARTDISEASE -- 2.1. Serotonin Metabolism -- 2.2. The Serotonin Transporter (SERT) -- 2.3. Role of the 5-HT2B Receptor in Drug-Induced Valvular Heart Disease -- 3. MORPHOLOGICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS -- 3.1. Histopathological Features
|
| 505 |
8 |
|
|a 3.2. Echocardiographical Characteristics4. DRUGS ASSOCIATED WITH VALVULAR HEART DISEASE -- 4.1. Ergotamine and Methysergide -- 4.2. Fenfluramine/Phentermine and Dexfenfluramine -- 4.3. Pergolide and Cabergoline -- 4.4. Bromocriptine -- 4.5. 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy�) -- 4.6. Other Drugs -- 5. INFLUENCE OF DRUG DOSE, TREATMENT DURATIONAND RISK FACTORS -- 6. NATURAL COURSE OF TOXIC VALVULOPATHY -- 7. SMALL ANIMAL MODELS OF DRUG-INDUCEDVALVULAR HEART DISEASE -- 8. PRACTICAL RECOMMENDATIONS FOR THE USE OF POTENTIALVALVULOPATHIC DRUGS
|
| 505 |
8 |
|
|a ABBREVIATIONSREFERENCES -- SHARED SUSCEPTIBILITY GENES OF METABOLICSYNDROME AND CARDIOVASCULAR DISEASE -- ABSTRACT -- INTRODUCTION -- The Renin Angiotensin System -- Trigylecrid Metabolism Affecting Genetic Variants -- Genetic Factors in Glucose Homeostasis -- Mutations Involved in Inflammatory Pathways -- Other Contributing Genetic Factors -- CONCLUDING REMARKS -- REFERENCES -- CARDIAC PACING: A REVIEW CHAPTER -- ABSTRACT -- INTRODUCTION -- ELECTRICAL CONDUCTION -- Blood Pressure -- Cardiac Output -- Stroke Volume
|
| 505 |
8 |
|
|a CLINICAL CARDIAC PACING INDICATIONSAtrioventricular (AV) Block -- Sinus Node Abnormalities -- INTRAVENTRICULAR CONDUCTION -- Cardiac Pacing Therapies -- Transcutaneous Pacing -- Temporary Transvenous Pacing -- Permanent Transvenous Pacing -- OVERVIEW OF PACEMAKERS -- Single Chamber Pacing Operation -- TRANSESOPHAGEAL PACING AND MECHANICAL CARDIAC PACING -- Transesophageal Pacing -- Mechanical Cardiac Pacing -- Pharmacological Remedies -- FOLLOW-UP -- SUMMARY -- REFERENCES
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Cardiovascular system
|x Diseases.
|
| 650 |
1 |
2 |
|a Cardiovascular Diseases
|
| 650 |
|
6 |
|a Appareil cardiovasculaire
|x Maladies.
|
| 650 |
|
7 |
|a MEDICAL
|x Cardiology.
|2 bisacsh
|
| 650 |
|
7 |
|a Cardiovascular system
|x Diseases
|2 fast
|
| 700 |
1 |
|
|a Bennington, Eleanor H.
|
| 758 |
|
|
|i has work:
|a Volume 2 Horizons in world cardiovascular research (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFwb8W9Fqfd4KGMBFfhyMK
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Bennington, Eleanor H.
|t Horizons in World Cardiovascular Research.
|d Hauppauge : Nova Science Publishers, Inc., ©2010
|z 9781616686109
|
| 830 |
|
0 |
|a Horizons in world cardiovascular research series.
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3018044
|z Texto completo
|
| 938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL3018044
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 383220
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 7161531
|
| 994 |
|
|
|a 92
|b IZTAP
|
